Folger Nolan Fleming Douglas Capital Management Inc. Decreases Stake in iShares Biotechnology ETF $IBB

Folger Nolan Fleming Douglas Capital Management Inc. lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 62,617 shares of the financial services provider’s stock after selling 1,495 shares during the period. Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in iShares Biotechnology ETF were worth $7,922,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Trust Co. of Toledo NA OH purchased a new position in shares of iShares Biotechnology ETF in the second quarter worth $32,000. Vontobel Holding Ltd. raised its holdings in shares of iShares Biotechnology ETF by 6.7% in the second quarter. Vontobel Holding Ltd. now owns 5,464 shares of the financial services provider’s stock worth $691,000 after buying an additional 341 shares during the last quarter. Rye Brook Capital LLC raised its holdings in shares of iShares Biotechnology ETF by 13.0% in the second quarter. Rye Brook Capital LLC now owns 24,300 shares of the financial services provider’s stock worth $3,074,000 after buying an additional 2,800 shares during the last quarter. Massachusetts Wealth Management raised its holdings in shares of iShares Biotechnology ETF by 12.6% in the second quarter. Massachusetts Wealth Management now owns 2,803 shares of the financial services provider’s stock worth $355,000 after buying an additional 313 shares during the last quarter. Finally, Bar Harbor Wealth Management raised its holdings in shares of iShares Biotechnology ETF by 1.8% in the second quarter. Bar Harbor Wealth Management now owns 15,568 shares of the financial services provider’s stock worth $1,970,000 after buying an additional 276 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.4%

NASDAQ IBB opened at $149.95 on Friday. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $153.01. The company has a fifty day simple moving average of $140.94 and a two-hundred day simple moving average of $130.60.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were paid a $0.0828 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.